NCT03927989

Tobacco Treatment in the Context of Lung Cancer Screening

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Medical University of South Carolina · Academic / Other
• Sex: All
• Age: 55 Years
• Healthy volunteers: Accepted

Summary

The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.

Detailed description

Screening for lung cancer at earlier, more treatable stages has the potential to reduce mortality from the U.S.'s most deadly cancer. Annual lung cancer screening with low-dose computed tomography is now recommended for high risk individuals based on age and smoking history. This study will evaluate a smoking cessation intervention for lung cancer screening patients. We will evaluate quit rates after a standard intervention (brief counseling session at time of lung cancer screening) versus a dual nicotine replacement therapy (NRT) and gain-framed text messaging intervention.

Conditions

• Smoking Cessation

Interventions

Type	Name	Description
BEHAVIORAL	Text messaging plus nicotine replacement therapy	Brief advice to quit smoking prior to lung cancer screening (LCS), 8 weeks of gain-framed, LCS-tailored text messages, and nicotine replacement therapy.
OTHER	Standard Care at Lung Cancer Screening	Brief advice to quit smoking prior to lung cancer screening

Timeline

• Start date: 2019-04-15
• Primary completion: 2023-10-19
• Completion: 2024-02-01
• First posted: 2019-04-25
• Last updated: 2024-11-22
• Results posted: 2024-11-22

Locations

1 site across 1 country: United States